4552
JP:CO:JCRPHARM
JCRファーマ株式会社
- Stock
Last Close
679.00
08/11 06:45
Market Cap
77.50B
Beta: -
Volume Today
248.10K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 1.68B - | 2.33B 39.16% | 2.46B 5.35% | 2.49B 1.36% | 3.90B 56.25% | 4.93B 26.52% | 3.42B 30.56% | 8.65B 152.86% | 19.40B 124.25% | 5.41B 72.11% | 5.51B 1.77% | |
depreciation and amortization | 1.11B - | 1.35B 21.62% | 1.41B 4.09% | 1.45B 2.83% | 1.38B 4.53% | 1.34B 2.82% | 1.43B 6.78% | 1.89B 31.94% | 1.95B 2.80% | 2.00B 2.67% | 3.20B 60.09% | |
deferred income tax | -392.77M - | -1.26B 220.04% | -145M 88.46% | -1.31B 803.45% | -1.29B 1.45% | -983M 23.86% | -3.07B 212.72% | -9.22B 199.97% | ||||
stock based compensation | 85.59M - | 79.35M 7.29% | 77M 2.96% | 144M 87.01% | 175M 21.53% | 149M 14.86% | 177M 18.79% | 173M 2.26% | ||||
change in working capital | 2.30B - | -2.18B 194.77% | -1.63B 25.12% | -208.19M 87.24% | -2.39B 1,048.45% | -1.58B 33.71% | 1.40B 188.20% | 323M 76.90% | -9.03B 2,895.67% | -2.96B 67.26% | -3.54B 19.69% | |
accounts receivables | -1.73B - | 857M 149.48% | -205M 123.92% | -7.40B 3,510.73% | 4.45B 160.09% | -3.39B 176.21% | ||||||
inventory | -138.81M - | -1.29B 831.11% | -947.05M 26.73% | -402.92M 57.46% | -1.31B 226.12% | -157M 88.05% | 258M 264.33% | -4.70B 1,921.32% | -1.08B 76.97% | -3.88B 258.32% | -2.44B 37.14% | |
accounts payables | 92M - | 2.25B 2,348.91% | -1.61B 171.37% | 238M 114.80% | -672M 382.35% | |||||||
other working capital | 2.44B - | -886.05M 136.35% | -684.33M 22.77% | 194.72M 128.45% | -1.08B 653.09% | 304M 128.23% | 191M 37.17% | 2.97B 1,457.07% | 1.06B 64.29% | -3.77B 454.52% | 2.96B 178.65% | |
other non cash items | -522.86M - | -1.01B 93.00% | -119.38M 88.17% | -1.16B 871.83% | 315M 127.15% | 385M 22.22% | -211M 154.81% | 307M 245.50% | -133M 143.32% | -905M 580.45% | 17.04B 1,982.65% | |
net cash provided by operating activities | 4.57B - | 499.05M 89.07% | 2.20B 341.19% | 2.65B 20.42% | 3.13B 18.17% | 3.90B 24.64% | 4.93B 26.17% | 10.34B 109.88% | 9.29B 10.17% | -5.50B 159.21% | 9.31B 269.31% | |
investments in property plant and equipment | -2.41B - | -1.34B 44.38% | -1.41B 5.50% | -1.55B 9.67% | -999M 35.57% | -895M 10.41% | -4.84B 440.56% | -7.53B 55.58% | -11.33B 50.56% | -8.56B 24.47% | -2.10B 75.53% | |
acquisitions net | 64.58M - | -62.66M 197.03% | -11M - | -2.75B - | 8.17B 397.31% | -6.72B 182.25% | -600M 91.07% | |||||
purchases of investments | -1.07B - | -2.04B 90.37% | -724.40M 64.50% | -42.77M 94.10% | -1.10B 2,483.65% | -100M 90.95% | -30M 70% | -391M 1,203.33% | -300M 23.27% | -906M 202% | ||
sales maturities of investments | 750.18M - | 1.96B 160.95% | 1.18B 39.57% | 736.33M 37.75% | 450M 38.89% | 1.26B 179.33% | 798M 36.52% | 584M 26.82% | 300M 48.63% | 259M 13.67% | ||
other investing activites | 63.03M - | -59.06M 193.69% | -25.20M 57.33% | 15.65M 162.09% | 78M 398.50% | -22M 128.21% | -91M 313.64% | 6.79B 7,562.64% | -84M 101.24% | 922M 1,197.62% | 5M 99.46% | |
net cash used for investing activites | -2.67B - | -1.42B 46.79% | -980.60M 30.93% | -841.40M 14.19% | -1.59B 88.61% | 240M 115.12% | -4.16B 1,833.75% | -3.29B 20.93% | -3.25B 1.22% | -15.00B 361.60% | -2.69B 82.07% | |
debt repayment | -580.60M - | -665.26M 14.58% | -759.46M 14.16% | -550.28M 27.54% | -233M 57.66% | -413M 77.25% | -850M 105.81% | -650M 23.53% | -750M 15.38% | -3.05B 306.67% | -500M 83.61% | |
common stock issued | 387M - | 3.87B 901.03% | 10.02B 158.72% | 740M 92.62% | 7.73B 944.32% | 15M 99.81% | ||||||
common stock repurchased | 26M - | 15M 42.31% | 13M 13.33% | 10M 23.08% | 10M 0% | 15M 50% | ||||||
dividends paid | -412.51M - | -592.41M 43.61% | -640.03M 8.04% | -699.28M 9.26% | -748M 6.97% | -834M 11.50% | -989M 18.59% | -1.08B 9.50% | -2.17B 100.28% | -2.74B 26.28% | -2.50B 8.73% | |
other financing activites | 623.66M - | -3.69M 100.59% | 85.47M 2,418.72% | 1.40B 1,533.19% | -1.19B 185.54% | -83M 93.05% | -2M 97.59% | 1M 150% | -10M 1,100% | -1M 90% | -46M 4,500% | |
net cash used provided by financing activities | -369.45M - | -1.26B 241.42% | -1.31B 4.18% | 146.30M 111.13% | -2.17B 1,586.65% | -917M 57.84% | 2.05B 323.34% | 8.30B 305.47% | -2.18B 126.24% | 1.95B 189.40% | -2.03B 204.26% | |
effect of forex changes on cash | 104.45M - | 44.30M 57.58% | -27.15M 161.28% | -15.04M 44.61% | 14M 193.10% | 12M 14.29% | 20M 66.67% | -22M 210% | 612M 2,881.82% | 1.10B 79.58% | 886M 19.38% | |
net change in cash | 1.63B - | -2.14B 230.98% | -120.03M 94.39% | 1.94B 1,717.31% | -614M 131.63% | 3.24B 627.85% | 2.84B 12.47% | 15.33B 440.43% | 4.47B 70.83% | -17.45B 490.23% | 5.48B 131.38% | |
cash at beginning of period | 4.15B - | 5.78B 39.34% | 3.64B 36.98% | 3.52B 3.29% | 5.46B 55.08% | 4.85B 11.24% | 8.09B 66.82% | 10.93B 35.06% | 26.26B 140.30% | 30.73B 17.03% | 13.28B 56.80% | |
cash at end of period | 5.78B - | 3.64B 36.98% | 3.52B 3.29% | 5.46B 55.10% | 4.85B 11.25% | 8.09B 66.82% | 10.93B 35.06% | 26.26B 140.30% | 30.73B 17.03% | 13.28B 56.80% | 18.76B 41.26% | |
operating cash flow | 4.57B - | 499.05M 89.07% | 2.20B 341.19% | 2.65B 20.42% | 3.13B 18.17% | 3.90B 24.64% | 4.93B 26.17% | 10.34B 109.88% | 9.29B 10.17% | -5.50B 159.21% | 9.31B 269.31% | |
capital expenditure | -2.41B - | -1.34B 44.38% | -1.41B 5.50% | -1.55B 9.67% | -999M 35.57% | -895M 10.41% | -4.84B 440.56% | -7.53B 55.58% | -11.33B 50.56% | -8.56B 24.47% | -2.10B 75.53% | |
free cash flow | 2.16B - | -841.23M 139.02% | 787.81M 193.65% | 1.10B 39.72% | 2.13B 93.87% | 3.01B 41.05% | 89M 97.04% | 2.81B 3,061.80% | -2.04B 172.64% | -14.06B 587.87% | 7.22B 151.33% |
All numbers in (except ratios and percentages)